ACCORD and HIPRA Enter into Exclusive Distribution Agreement to Commercialise HIPRA’s COVID-19 vaccine (BIMERVAX®) in the United Kingdom
(Adnkronos) – BIMERVAX®: A booster dose of bivalent recombinant protein vaccine provides immunisation in people over 16 years of age LONDON and GIRONA, Spain, Aug. 4, 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord)
